SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001213900-21-045165
Filing Date
2021-08-27
Accepted
2021-08-26 21:05:31
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE REVISED PROXY STATEMENT ea146534-defr14a_adialpharma.htm DEFR14A 19306
2 GRAPHIC proxy_001.jpg GRAPHIC 170427
  Complete submission text file 0001213900-21-045165.txt   255338
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 001-38323 | Film No.: 211213907
SIC: 2834 Pharmaceutical Preparations